valienamine has been researched along with arginine in 1 studies
| Studies (valienamine) | Trials (valienamine) | Recent Studies (post-2010) (valienamine) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 46 | 0 | 10 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | valienamine (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higaki, K; Iida, M; Iwasaki, H; Nanba, E; Ogawa, S; Suzuki, Y; Tabe, M; Watanabe, H | 1 |
1 other study(ies) available for valienamine and arginine
| Article | Year |
|---|---|
Fibroblast screening for chaperone therapy in beta-galactosidosis.
Topics: Arginine; beta-Galactosidase; Cells, Cultured; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibroblasts; Gangliosidosis, GM1; Genotype; Glutamine; Hexosamines; Humans; Molecular Chaperones; Mucopolysaccharidosis IV; Mutation; Phenotype | 2006 |